Flt-3 and c-kit mutation studies in a spectrum of chronic myeloid disorders including systemic mast cell disease

Animesh D Pardanani, Terra L. Reeder, Teresa K. Kimlinger, Jin Y. Baek, Chin Y. Li, Joseph H. Butterfield, Ayalew Tefferi

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

We screened 115 patients with chronic myeloid disorders (CMD) for known flt-3 and c-kit mutations in both the juxtamembrane (JM) and the activation loop (AL) domains. None of the patients displayed flt-3 (JM or AL) or c-kit JM mutations. However, the c-kit AL (D816V) mutation was detected in 5 of 16 patients with systemic mast cell disease (SMCD) but in none of the remaining 99 patients with other CMD. In SMCD, the presence of D816V mutation was significantly associated with advanced age, an aggressive clinical course, increased bone marrow mast cell content, and chronic myelomonocytic leukemia.

Original languageEnglish (US)
Pages (from-to)739-742
Number of pages4
JournalLeukemia Research
Volume27
Issue number8
DOIs
StatePublished - Aug 1 2003

Fingerprint

Systemic Mastocytosis
Mutation
Leukemia, Myelomonocytic, Chronic
Mast Cells
Bone Marrow Cells

Keywords

  • c-kit mutation
  • Hematologic clonal malignancies
  • Leukemia
  • Receptor tyrosine kinase
  • Stem cells

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Flt-3 and c-kit mutation studies in a spectrum of chronic myeloid disorders including systemic mast cell disease. / Pardanani, Animesh D; Reeder, Terra L.; Kimlinger, Teresa K.; Baek, Jin Y.; Li, Chin Y.; Butterfield, Joseph H.; Tefferi, Ayalew.

In: Leukemia Research, Vol. 27, No. 8, 01.08.2003, p. 739-742.

Research output: Contribution to journalArticle

Pardanani, Animesh D ; Reeder, Terra L. ; Kimlinger, Teresa K. ; Baek, Jin Y. ; Li, Chin Y. ; Butterfield, Joseph H. ; Tefferi, Ayalew. / Flt-3 and c-kit mutation studies in a spectrum of chronic myeloid disorders including systemic mast cell disease. In: Leukemia Research. 2003 ; Vol. 27, No. 8. pp. 739-742.
@article{830560e764ec40e29199a0a030eb5b09,
title = "Flt-3 and c-kit mutation studies in a spectrum of chronic myeloid disorders including systemic mast cell disease",
abstract = "We screened 115 patients with chronic myeloid disorders (CMD) for known flt-3 and c-kit mutations in both the juxtamembrane (JM) and the activation loop (AL) domains. None of the patients displayed flt-3 (JM or AL) or c-kit JM mutations. However, the c-kit AL (D816V) mutation was detected in 5 of 16 patients with systemic mast cell disease (SMCD) but in none of the remaining 99 patients with other CMD. In SMCD, the presence of D816V mutation was significantly associated with advanced age, an aggressive clinical course, increased bone marrow mast cell content, and chronic myelomonocytic leukemia.",
keywords = "c-kit mutation, Hematologic clonal malignancies, Leukemia, Receptor tyrosine kinase, Stem cells",
author = "Pardanani, {Animesh D} and Reeder, {Terra L.} and Kimlinger, {Teresa K.} and Baek, {Jin Y.} and Li, {Chin Y.} and Butterfield, {Joseph H.} and Ayalew Tefferi",
year = "2003",
month = "8",
day = "1",
doi = "10.1016/S0145-2126(02)00303-X",
language = "English (US)",
volume = "27",
pages = "739--742",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",
number = "8",

}

TY - JOUR

T1 - Flt-3 and c-kit mutation studies in a spectrum of chronic myeloid disorders including systemic mast cell disease

AU - Pardanani, Animesh D

AU - Reeder, Terra L.

AU - Kimlinger, Teresa K.

AU - Baek, Jin Y.

AU - Li, Chin Y.

AU - Butterfield, Joseph H.

AU - Tefferi, Ayalew

PY - 2003/8/1

Y1 - 2003/8/1

N2 - We screened 115 patients with chronic myeloid disorders (CMD) for known flt-3 and c-kit mutations in both the juxtamembrane (JM) and the activation loop (AL) domains. None of the patients displayed flt-3 (JM or AL) or c-kit JM mutations. However, the c-kit AL (D816V) mutation was detected in 5 of 16 patients with systemic mast cell disease (SMCD) but in none of the remaining 99 patients with other CMD. In SMCD, the presence of D816V mutation was significantly associated with advanced age, an aggressive clinical course, increased bone marrow mast cell content, and chronic myelomonocytic leukemia.

AB - We screened 115 patients with chronic myeloid disorders (CMD) for known flt-3 and c-kit mutations in both the juxtamembrane (JM) and the activation loop (AL) domains. None of the patients displayed flt-3 (JM or AL) or c-kit JM mutations. However, the c-kit AL (D816V) mutation was detected in 5 of 16 patients with systemic mast cell disease (SMCD) but in none of the remaining 99 patients with other CMD. In SMCD, the presence of D816V mutation was significantly associated with advanced age, an aggressive clinical course, increased bone marrow mast cell content, and chronic myelomonocytic leukemia.

KW - c-kit mutation

KW - Hematologic clonal malignancies

KW - Leukemia

KW - Receptor tyrosine kinase

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=0038204191&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038204191&partnerID=8YFLogxK

U2 - 10.1016/S0145-2126(02)00303-X

DO - 10.1016/S0145-2126(02)00303-X

M3 - Article

VL - 27

SP - 739

EP - 742

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 8

ER -